U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
84-329-Immunoglobulin G1 [135-tyrosine,137-threonine,139-glutamic acid] (human ?1-chain constant region), dimer, N6-[15-[4-[20-carboxy-14-[2-[2-(carboxymethylamino)ethoxy]ethyl]-2,5,8,11,17-pentaoxa-14,20-diazaheneicos-1-yl]-1H-1,2,3-triazol-1-yl]-1-oxo-
Preferred Name English
Efitazanamivir alfa
INN  
Official Name English
efitazanamivir alfa [INN]
Common Name English
Fc fragment of human immunoglobulin G1 (1-247) [Homo sapiens IGHG1*01(CH1 final 15 residues (1-15), hinge (16-30), CH2 M<sup>52</sup>>Y, S<sup>54</sup>>T, T<sup>56</sup>>E (31-140), CH3 (141-245), CHS (246-247))], dimer (26-26':29-29')-bisdisulfide, prod
Common Name English
Code System Code Type Description
FDA UNII
7CA5JND7QE
Created by admin on Wed Apr 02 10:56:05 GMT 2025 , Edited by admin on Wed Apr 02 10:56:05 GMT 2025
PRIMARY
CAS
2781830-14-4
Created by admin on Wed Apr 02 10:56:05 GMT 2025 , Edited by admin on Wed Apr 02 10:56:05 GMT 2025
PRIMARY
INN
13066
Created by admin on Wed Apr 02 10:56:05 GMT 2025 , Edited by admin on Wed Apr 02 10:56:05 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966